Thomas Knösel
LMU Klinikum · 360 works · 8,150 citations · h-index 51
Top works
- Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis
- ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival
- The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma
- Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma
- MRI of Prostate Cancer at 1.5 and 3.0 T: Comparison of Image Quality in Tumor Detection and Staging
- International Histopathology Consensus for Unilateral Primary Aldosteronism
- Single-center study: the diagnostic performance of contrast-enhanced ultrasound (CEUS) for assessing renal oncocytoma
- Nuclear relocation of STAT 6 reliably predicts NAB2 – STAT6 fusion for the diagnosis of solitary fibrous tumour
- Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab
- Current diagnostics and treatment of fibrosarcoma -perspectives for future therapeutic targets and strategies
- TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): Analysis of 319 cases
- Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes
- Incidence of chromosomal imbalances in advanced colorectal carcinomas and their metastases
- Nuclear export is essential for the tumor‐promoting activity of survivin
- MicroRNAs Cooperatively Inhibit a Network of Tumor Suppressor Genes to Promote Pancreatic Tumor Growth and Progression
- Survival and prognostic factors in conventional central chondrosarcoma
- Immunoprofiles of 11 Biomarkers Using Tissue Microarrays Identify Prognostic Subgroups in Colorectal Cancer
- Chromosomal Imbalances in Brain Metastases of Solid Tumors
- Chromosomal Alterations during Lymphatic and Liver Metastasis Formation of Colorectal Cancer
- Aneurysmal bone cyst: results of an off label treatment with Denosumab